Biocon added 1.54% to Rs 260.55 after the company announced that it has received approval from the Medicines and Healthcare Products Regulatory Agency (MHRA), U.K., for its complex formulation Liraglutide.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
